Premium
Plasma Fibronectin Deficiency during Chemotherapy of Acute Myeloid Leukaemia
Author(s) -
Brodin Bengt,
Liedén Gudrun,
Malm Claes,
Vikrot Olle
Publication year - 1983
Publication title -
scandinavian journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 84
eISSN - 1600-0609
pISSN - 0036-553X
DOI - 10.1111/j.1600-0609.1983.tb01485.x
Subject(s) - fibronectin , myeloid leukaemia , chemotherapy , medicine , myeloid , chronic myeloid leukaemia , immunology , gastroenterology , chemistry , cell , biochemistry
Plasma fibronectin was determined using a laser nephelometric method in 10 patients with acute myeloid leukaemia undergoing chemotherapy. There was a continous fall during the first 3 weeks to about 50% of the normal level. The decrease of fibronectin may contribute to the lowered resistence against infection characteristic of these patients.